U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H29N5O2
Molecular Weight 359.4659
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAVOLTIDINE

SMILES

CN1N=C(CO)N=C1NCCCOC2=CC=CC(CN3CCCCC3)=C2

InChI

InChIKey=VTLNPNNUIJHJQB-UHFFFAOYSA-N
InChI=1S/C19H29N5O2/c1-23-19(21-18(15-25)22-23)20-9-6-12-26-17-8-5-7-16(13-17)14-24-10-3-2-4-11-24/h5,7-8,13,25H,2-4,6,9-12,14-15H2,1H3,(H,20,21,22)

HIDE SMILES / InChI

Molecular Formula C19H29N5O2
Molecular Weight 359.4659
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

LAVOLTIDINE, also known as loxtidine, is a highly potent and selective histamine H2-receptor antagonist. It is a member of triazoles. It produces gastric carcinoid tumors in rodents that is why its clinical development was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.
2005 Jun
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development.
2010 Jun 8
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:20:10 UTC 2023
Edited
by admin
on Fri Dec 15 17:20:10 UTC 2023
Record UNII
X16K5179V5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LAVOLTIDINE
INN  
INN  
Official Name English
LOXTIDINE
Common Name English
1H-1,2,4-TRIAZOLE-3-METHANOL, 1-METHYL-5-((3-(3-(1-PIPERIDINYLMETHYL)PHENOXY)PROPYL)AMINO)-
Systematic Name English
Lavoltidine [WHO-DD]
Common Name English
AH-23844 FREE BASE
Code English
lavoltidine [INN]
Common Name English
1-METHYL-5-((3-((.ALPHA.-PIPERIDINO-M-TOLYL)OXY)PROPYL)AMINO)-1H-1,2,4-TRIAZOLE-3-METHANOL
Systematic Name English
LOXOTIDINE
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID0020785
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
FDA UNII
X16K5179V5
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
ChEMBL
CHEMBL2110857
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
INN
5272
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
DRUG BANK
DB12884
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
MESH
C039993
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
EVMPD
SUB08417MIG
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
PUBCHEM
55473
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
NCI_THESAURUS
C170098
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
CHEBI
6550
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
SMS_ID
100000082582
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
CAS
76956-02-0
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
WIKIPEDIA
Lavoltidine
Created by admin on Fri Dec 15 17:20:10 UTC 2023 , Edited by admin on Fri Dec 15 17:20:10 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY